Summary
- Current Price
- As of today, BCAX price is $24.28, up +2.75% on
- Current Price All-Time High
- BCAX price is currently -21.65% below its historical high of $30.99 set on
- Market Cap
- BCAX current market cap is $2B, up +158.11% over the past 365 days
- Revenue
- BCAX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for BCAX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Bicara Therapeutics Inc. |
| Ticker | NASDAQ: BCAX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | bicara.com |
| Employees | 55 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $24.28 | |
| Price, 1D Change | +2.75% | |
| $2B | ||
| - | ||
| - | ||
| 0.94 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.52 | ||
| EPS, 1Y Change | -102.00% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$2.52 | ||
| EPS Estimate | -$3.40 | N/A |
| EPS Est. Change | -34.73% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $24.28 | |
| Price Target | $34.00 | - |
| Price Tgt. Change | +40.03% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.64 | -$1.25 | +52.73% | |
| -$2.48 | -$2.52 | -1.77% | |
| -$3.40 | N/A | -34.73% | |
| -$3.59 | N/A | -42.46% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $24.28 | |
| $20.31 | ||
| $25.83 | ||
| $21.31 | ||
| $25.69 | ||
| -$0.40 | ||
| 0.94 | ||
| $1.63 | ||
| 40.51 | ||
| 79.72% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$2.52 | ||
| -$105.00K | ||
| - | ||
| -$155.60M | ||
| - | ||
| -$137.95M | ||
| - | ||
| -$155.50M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 14.58 | ||
| 14.58 | ||
| - | ||
| - | ||
| 6.51 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 3.13 | ||
| -6.14 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $401.45M | ||
| $414.80M | ||
| $529.30M | ||
| $422.05M | ||
| $127.85M | ||
| $28.95M | ||
| $1.71M | ||
| $1.12M | ||
| $7.79M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $137.95M | ||
| $155.50M | ||
| $105.00K | ||
| $0.00 | ||
| $105.00K | ||
| $0.00 | ||
| $217.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$106.83M | ||
| -$318.45M | ||
| $32.26M | ||
| $280.00K | ||
| -$107.11M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wells Fargo | → | |
| Wedbush | → | |
| Morgan Stanley | → | |
| Mizuho | → | |
| Goldman Sachs | → | |
| BTIG | → | |
| Morgan Stanley | → | |
| Goldman Sachs | → | |
| Guggenheim | ||
| Wells Fargo | → |
Analyst sentiment
Institutional ownership
No data
Screeners with BCAX
FAQ
- What is the ticker symbol for Bicara Therapeutics Inc.?
- The ticker symbol for Bicara Therapeutics Inc. is NASDAQ:BCAX
- Does Bicara Therapeutics Inc. pay dividends?
- No, Bicara Therapeutics Inc. does not pay dividends
- What sector is Bicara Therapeutics Inc. in?
- Bicara Therapeutics Inc. is in the Healthcare sector
- What industry is Bicara Therapeutics Inc. in?
- Bicara Therapeutics Inc. is in the Biotechnology industry
- What country is Bicara Therapeutics Inc. based in?
- Bicara Therapeutics Inc. is headquartered in United States
- When did Bicara Therapeutics Inc. go public?
- Bicara Therapeutics Inc. initial public offering (IPO) was on September 13, 2024
- Is Bicara Therapeutics Inc. in the S&P 500?
- No, Bicara Therapeutics Inc. is not included in the S&P 500 index
- Is Bicara Therapeutics Inc. in the NASDAQ 100?
- No, Bicara Therapeutics Inc. is not included in the NASDAQ 100 index
- Is Bicara Therapeutics Inc. in the Dow Jones?
- No, Bicara Therapeutics Inc. is not included in the Dow Jones index
- When was Bicara Therapeutics Inc. last earnings report?
- Bicara Therapeutics Inc.'s most recent earnings report was on August 11, 2026
- When does Bicara Therapeutics Inc. report earnings?
- The next expected earnings date for Bicara Therapeutics Inc. is November 10, 2026
Data Sources & References
- BCAX Official Website www.bicara.com
- BCAX Profile on Yahoo Finance finance.yahoo.com/quote/BCAX
- BCAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bcax